• English
  • Deutsch
  • Log In
    Password Login
    or
  • Research Outputs
  • Projects
  • Researchers
  • Institutes
  • Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. EU policies in personalized medicine-related technologies
 
  • Details
  • Full
Options
2009
Journal Article
Titel

EU policies in personalized medicine-related technologies

Abstract
Against the background of a number of first drug-diagnostic co-products developed and introduced into the European market, European decision-makers feel impelled to react and position themselves in the field of personalized medicine. Their reactions cover a broad range, from the analysis of knowledge requirements for market approval to the need for translational activities and the possible contribution of pharmacogenetics to public health. This article summarizes the current positions of European institutions, based on literature review and expert consultation for three items associated with personalized medicine: biobanks, genetic diagnostics and drug-diagnostic co-products, and provides an outlook on requirements for an effective future European policy on personalized medicine.
Author(s)
Gaisser, S.
Vignola-Gagne, E.
Husing, B. orcid-logo
Enzing, C.
Valk, T. van der
Zeitschrift
Personalized medicine
Thumbnail Image
DOI
10.2217/17410541.6.1.93
Language
English
google-scholar
Fraunhofer-Institut für System- und Innovationsforschung ISI
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Send Feedback
© 2022